Clinical Trial: THROMBOTIC MICROANGIOPATHY (TMA) ASSOCIATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN ADULT PATIENTS

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07059026) titled 'THROMBOTIC MICROANGIOPATHY (TMA) ASSOCIATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN ADULT PATIENTS' on July 01.

Brief Summary: Thrombotic Microangiopathy (TMA) Associated with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is a serious complication that is associated with increased morbidity, related to multiple organ failure, with increased mortality in transplant patients. The incidence and evolution of TMA, especially in the adult population, is unclear due to the lack of early systematic screening and clear criteria for its diagnosis. For this reason, we designed this protocol to study the in...